FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093622484> ?p ?o ?g. }

• W2093622484 endingPage "30393" @default.
• W2093622484 startingPage "30388" @default.
• W2093622484 abstract "The multiprotein von Hippel-Lindau (VHL) tumor suppressor (CBCVHL, Cul2-ElonginBC-VHL) and SCF (Skp1-Cul1/Cdc53-F-box protein) complexes are members of structurally related families of E3 ubiquitin ligases that use a heterodimeric module composed of a member of the Cullin protein family and the RING finger protein Rbx1 (ROC1/Hrt1) to activate ubiquitylation of target proteins by the E2 ubiquitin-conjugating enzymes Ubc5 and Cdc34. VHL and F-box proteins function as the substrate recruitment subunits of CBCVHLand SCF complexes, respectively. In cells, many F-box proteins are short lived and are proposed to be ubiquitylated by an autocatalytic mechanism and destroyed by the proteasome following assembly into SCF complexes. In contrast, the VHL protein is stabilized by interaction with the Elongin B and C subunits of CBCVHL in cells. In this report, we have presented direct biochemical evidence that unlike the F-box protein Cdc4, which is ubiquitylated in vitro by Cdc34 in the context of the SCF, the VHL protein is protected from Ubc5-catalyzed ubiquitylation following assembly into the CBCVHL complex. CBCVHL is continuously required for negative regulation of hypoxia-inducible transcription factors in normoxic cells and of SCF complexes, many of which function only transiently during the cell cycle or in response to cellular signals. Our findings provide a molecular basis for the different modes of cellular regulation of VHL and F-box proteins and are consistent with the known roles of CBCVHL. The multiprotein von Hippel-Lindau (VHL) tumor suppressor (CBCVHL, Cul2-ElonginBC-VHL) and SCF (Skp1-Cul1/Cdc53-F-box protein) complexes are members of structurally related families of E3 ubiquitin ligases that use a heterodimeric module composed of a member of the Cullin protein family and the RING finger protein Rbx1 (ROC1/Hrt1) to activate ubiquitylation of target proteins by the E2 ubiquitin-conjugating enzymes Ubc5 and Cdc34. VHL and F-box proteins function as the substrate recruitment subunits of CBCVHLand SCF complexes, respectively. In cells, many F-box proteins are short lived and are proposed to be ubiquitylated by an autocatalytic mechanism and destroyed by the proteasome following assembly into SCF complexes. In contrast, the VHL protein is stabilized by interaction with the Elongin B and C subunits of CBCVHL in cells. In this report, we have presented direct biochemical evidence that unlike the F-box protein Cdc4, which is ubiquitylated in vitro by Cdc34 in the context of the SCF, the VHL protein is protected from Ubc5-catalyzed ubiquitylation following assembly into the CBCVHL complex. CBCVHL is continuously required for negative regulation of hypoxia-inducible transcription factors in normoxic cells and of SCF complexes, many of which function only transiently during the cell cycle or in response to cellular signals. Our findings provide a molecular basis for the different modes of cellular regulation of VHL and F-box proteins and are consistent with the known roles of CBCVHL. von Hippel-Lindau glutathione S-transferase dithiothreitol wild type high pressure liquid chromatography Cul2-Elongin BC Skp1-Cul1/Cdc53-F-box Ubiquitylation and the subsequent proteasomal degradation of regulatory proteins control a large number of cellular processes, including cell cycle progression, transcription, and signal transduction. Ubiquitin-dependent protein degradation is an elaborate, multistage process that begins with enzymatic tagging of target proteins with a polyubiquitin chain and culminates with ubiquitin-dependent degradation of tagged proteins by the 26 S proteasome (1Hochstrasser M. Curr. Opin. Cell Biol. 1995; 7: 215-223Crossref PubMed Scopus (775) Google Scholar, 2Hochstrasser M. Annu. Rev. Genet. 1996; 30: 405-439Crossref PubMed Scopus (1444) Google Scholar, 3Hershko A. Ciechanover A. Annu. Rev. Biochem. 1998; 67: 425-479Crossref PubMed Scopus (6736) Google Scholar, 4Pickart C. Annu. Rev. Biochem. 2001; 70: 503-533Crossref PubMed Scopus (2857) Google Scholar). In the first stage, the C terminus of ubiquitin is covalently bound through a thioester bond to the active site cysteine residue of an E1 ubiquitin-activating enzyme. Ubiquitin is then transferred from the E1 to an active site cysteine residue in one of a number of E2 ubiquitin-conjugating enzymes. Finally, in a reaction mediated by an E3 ubiquitin ligase, ubiquitin is conjugated directly via isopeptide bonds to ε-amino groups of lysines in the target protein and then to lysines in their ubiquityl moieties to complete synthesis of the polyubiquitin tag. The E3 components of the ubiquitin pathway are responsible for recognizing and recruiting target proteins for polyubiquitylation. The E3 fall into two functional classes (3Hershko A. Ciechanover A. Annu. Rev. Biochem. 1998; 67: 425-479Crossref PubMed Scopus (6736) Google Scholar, 5Joazeiro C.A.P. Weissman A.M. Cell. 2000; 102: 549-552Abstract Full Text Full Text PDF PubMed Scopus (1025) Google Scholar). One class includes the homologous to E6-AP carboxylterminus (HECT) domain proteins, which have an active site cysteine residue that receives ubiquitin from an E2 ubiquitin-conjugating enzyme and transfers it to target proteins. The other class includes the E3 that appear to activate ubiquitylation of target proteins at least in part by binding to both E2 ubiquitin-conjugating enzymes and target proteins and bringing them into close proximity. Among members of this class of E3s are the structurally related multiprotein SCF (Skp1-Cul1/Cdc53-F-box protein) and von Hippel-Lindau (VHL)1tumor suppressor (CBCVHL or Cul2-ElonginBC-VHL) complexes, which use heterodimeric modules composed of a member of the Cullin protein family and the RING finger protein Rbx1 (also referred to as ROC1 or Hrt1) to activate ubiquitylation of target proteins by the E2 ubiquitin-conjugating enzymes Cdc34 and Ubc5 (6Deshaies R.J. Annu. Rev. Cell Dev. Biol. 1999; 15: 435-467Crossref PubMed Scopus (1078) Google Scholar, 7Tyers M. Jorgenson P. Curr. Opin. Genet. Dev. 2000; 10: 54-64Crossref PubMed Scopus (268) Google Scholar). SCF ubiquitin ligases include a member of the F-box family of proteins, which serve to recognize and recruit target proteins. F-box proteins are linked to a Cul1(Cdc53)/Rbx1 module by the Skp1 adaptor protein that binds to a degenerate, ∼40-amino acid sequence motif called the F-box, which is present in F-box proteins (8Bai C. Sen P. Hofmann K., Ma, L. Goebl M. Harper J.W. Elledge S.J. Cell. 1996; 86: 263-274Abstract Full Text Full Text PDF PubMed Scopus (964) Google Scholar, 9Patton E.E. Willems A.R. Tyers M. Trends Genet. 1998; 14: 236-243Abstract Full Text Full Text PDF PubMed Scopus (442) Google Scholar). As a component of the CBCVHL ubiquitin ligase, the VHL tumor suppressor protein functions analogously to F-box proteins in the SCF complex to recruit target proteins for ubiquitylation (10Maxwell P.H. Wiggener M.S. Chang G.W. Clifford S.C. Vaux E.C. Cockman M.E. Wykoff C.C. Pugh C.W. Maher E.R. Ratcliffe P.J. Nature. 1999; 399: 271-275Crossref PubMed Scopus (4025) Google Scholar, 11Cockman M.E. Masson N. Mole D.R. Jaakkola P. Chang G.W. Clifford S.C. Maher E.R. Pugh C.W. Ratcliffe P.J. Maxwell P.H. J. Biol. Chem. 2000; 275: 25733-25741Abstract Full Text Full Text PDF PubMed Scopus (909) Google Scholar, 12Ohh M. Park C.W. Ivan M. Hoffman M.A. Kim T.Y. Huang L.E. Pavletich N. Chau V. Kaelin W.G. Nat. Cell Biol. 2000; 2: 423-427Crossref PubMed Scopus (1238) Google Scholar, 13Kamura T. Sato S. Iwai K. Czyzyk-Krezeska M.F. Conaway R.C. Conaway J.W. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 10430-10435Crossref PubMed Scopus (544) Google Scholar, 14Tanimoto K. Makino Y. Pereira T. Poellinger L. EMBO J. 2000; 19: 4298-4309Crossref PubMed Google Scholar). The VHL protein is linked to a Cul2/Rbx1 module by the ubiquitin-like Elongin B and Skp1-like Elongin C adaptor proteins. Elongins B and C form a stable subcomplex that binds to a short BC-box motif present in the VHL protein (15Kibel A. Iliopoulos O. DeCaprio J.A. Kaelin W.G. Science. 1995; 269: 1444-1446Crossref PubMed Scopus (566) Google Scholar, 16Duan D.R. Pause A. Burgess W.H. Aso T. Chen D.Y.T. Garrett K.P. Conaway R.C. Conaway J.W. Linehan W.M. Klausner R.D. Science. 1995; 269: 1402-1406Crossref PubMed Scopus (506) Google Scholar, 17Kishida T. Stackhouse T.M. Chen F. Lerman M.I. Zbar B. Cancer Res. 1995; 20: 4544-4548Google Scholar). F-box proteins, including mammalian Skp2 and Saccharomyces cerevisiae Cdc4, Grr1, and Met30, have recently been shown to be short lived proteins that are rapidly turned over with ubiquitin-dependent degradation by the proteasome when assembled into SCF complexes in cells (18Galan J.-M. Peter M. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 9124-9129Crossref PubMed Scopus (225) Google Scholar, 19Zhou P. Howley P.M. Mol. Cell. 1998; 2: 571-580Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar, 20Mathias N. Johnson S. Byers B. Goebl M. Mol. Cell. Biol. 1999; 19: 1759-1767Crossref PubMed Scopus (46) Google Scholar, 21Wirbelauer C. Sutterluty H. Blondel M. Gstaiger M. Peter M. Reymond F. Krek W. EMBO J. 2000; 19: 5362-5375Crossref PubMed Scopus (150) Google Scholar). Based on these findings, it has been proposed that these F-box proteins are ubiquitylated by an autocatalytic mechanism in the context of the SCF and, further, that rapid turnover of F-box proteins provides a mechanism for rapid assembly and disassembly of distinct SCF complexes required for timely responses of the cell to different cell cycle or environmental cues. In contrast to these F-box proteins, the VHL tumor suppressor protein is long lived in cells. In addition, whereas F-box proteins are stabilized in cells by mutations that prevent them from binding Skp1 and assembling into SCF complexes, VHL is destabilized by mutations that interfere with its ability to bind Elongins C and B and assemble into CBCVHL (22Schoenfeld A.R. Davidowitz E.J. Burk R.D. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 8507-8512Crossref PubMed Scopus (97) Google Scholar). Notably, the hypoxia-inducible transcription factors HIF1α and HIF2α were recently shown to be targets of the CBCVHL ubiquitin ligase (10Maxwell P.H. Wiggener M.S. Chang G.W. Clifford S.C. Vaux E.C. Cockman M.E. Wykoff C.C. Pugh C.W. Maher E.R. Ratcliffe P.J. Nature. 1999; 399: 271-275Crossref PubMed Scopus (4025) Google Scholar, 11Cockman M.E. Masson N. Mole D.R. Jaakkola P. Chang G.W. Clifford S.C. Maher E.R. Pugh C.W. Ratcliffe P.J. Maxwell P.H. J. Biol. Chem. 2000; 275: 25733-25741Abstract Full Text Full Text PDF PubMed Scopus (909) Google Scholar, 12Ohh M. Park C.W. Ivan M. Hoffman M.A. Kim T.Y. Huang L.E. Pavletich N. Chau V. Kaelin W.G. Nat. Cell Biol. 2000; 2: 423-427Crossref PubMed Scopus (1238) Google Scholar, 13Kamura T. Sato S. Iwai K. Czyzyk-Krezeska M.F. Conaway R.C. Conaway J.W. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 10430-10435Crossref PubMed Scopus (544) Google Scholar, 14Tanimoto K. Makino Y. Pereira T. Poellinger L. EMBO J. 2000; 19: 4298-4309Crossref PubMed Google Scholar). HIF1α and HIF2α are continuously synthesized in cells grown under normoxic conditions but are rapidly ubiquitylated by the CBCVHLcomplex and degraded by the proteasome. Under hypoxic conditions (23Huang L.E. Arany Z. Livingston D.M. Bunn H.F. J. Biol. Chem. 1996; 271: 32253-32259Abstract Full Text Full Text PDF PubMed Scopus (1008) Google Scholar, 24Salceda S. Caro J. J. Biol. Chem. 1997; 272: 22642-22647Abstract Full Text Full Text PDF PubMed Scopus (1381) Google Scholar, 25Huang L.E., Gu, J. Schau M. Bunn H.F. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 7987-7992Crossref PubMed Scopus (1820) Google Scholar) or in cells lacking a functional VHL gene (10Maxwell P.H. Wiggener M.S. Chang G.W. Clifford S.C. Vaux E.C. Cockman M.E. Wykoff C.C. Pugh C.W. Maher E.R. Ratcliffe P.J. Nature. 1999; 399: 271-275Crossref PubMed Scopus (4025) Google Scholar,26Iliopoulos O. Levy A.P. Jiang C. Kaelin W.G. Goldberg M.A. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 10595-10599Crossref PubMed Scopus (733) Google Scholar, 27Gnarra J.R. Zhou S. Merrill M.J. Wagner J.R. Krumm A. Papavassiliou E. Oldfield E.H. Klausner R.D. Linehan W.M. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 10589-10594Crossref PubMed Scopus (464) Google Scholar, 28Siemeister G. Weindel K. Mohrs K. Barleon B. Martiny-Baron G. Marme D. Cancer Res. 1996; 56: 2299-2301PubMed Google Scholar), HIF1α and HIF2α are stabilized and accumulate and activate expression of their target genes. Based on these findings, the longevity of the VHL protein in cells is likely to ensure that it can maintain close and continuous surveillance of hypoxia-inducible transcription factors, which may be activated at any time during the life of a cell. In this report, we have investigated the molecular basis of the different modes of regulation of VHL and F-box proteins. We have demonstrated that unlike the F-box protein Cdc4, which is ubiquitylatedin vitro by Cdc34 in the context of the SCF, the VHL protein is protected from Ubc5-catalyzed ubiquitylation in the context of CBCVHL even though the RING finger protein Rbx1 is capable of directly targeting VHL for ubiquitylation when it is not assembled into the CBCVHL complex. Our findings provide a plausible model to explain the differential stabilities of VHL and F-box proteins, and they suggest that the longevity of the VHL tumor suppressor protein is regulated at least in part by the geometry of the CBCVHL complex through the spatial organization of its surface lysine residues. Anti-VHL monoclonal antibody (Ig32) was purchased from BD PharMingen. Anti-Cul2 and anti-Elongin C monoclonal antibodies were obtained from Transduction Laboratories. Anti-Myc monoclonal antibody (9E10) was from Roche Molecular Biochemicals. Anti-protein C monoclonal antibody (HPC4) was a generous gift from C. T. Esmon (Oklahoma Medical Research Foundation). Anti-T7 monoclonal antibody was purchased from Invitrogen. Anti-HSV monoclonal antibody was obtained from Novagen. Anti-Elongin B rabbit polyclonal antibody has been described (29Garrett K.P. Aso T. Bradsher J.N. Foundling S.I. Lane W.S. Conaway R.C. Conaway J.W. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 7172-7176Crossref PubMed Scopus (91) Google Scholar). Human Ubc5a, human Ubc3 containing an N-terminal His6 tag, S. cerevisiae Uba1 containing an N-terminal Myc tag and a C-terminal His6, S. cerevisiae Cdc34 containing an N-terminal His6, and mouse ubiquitin-K48R containing an N-terminal GST tag (GST·UbK48R) were described previously (13Kamura T. Sato S. Iwai K. Czyzyk-Krezeska M.F. Conaway R.C. Conaway J.W. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 10430-10435Crossref PubMed Scopus (544) Google Scholar, 30Iwai K. Yamanaka K. Kamura T. Minato N. Conaway R.C. Conaway J.W. Klausner R.D. Pause A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 12436-12441Crossref PubMed Scopus (420) Google Scholar, 31Kamura T. Conrad M.N. Yan Q. Conaway R.C. Conaway J.W. Genes Dev. 1999; 13: 2928-2933Crossref PubMed Scopus (232) Google Scholar). Proteins were expressed in E. coli strain BL21 (DE3) and purified by Ni2+-agarose or glutathione-Sepharose affinity chromatography. After dialysis against 40 mm Hepes-NaOH (pH 7.9), 60 mm potassium acetate, 2 mm DTT, 1 mm MgCl2, 0.5 mm EDTA (pH 7.9), and 10% (v/v) glycerol, proteins were stored at −80 °C. Wild type human VHL and VHL mutants [K159R/K167R/K196R]VHL, [L158P]VHL, and [C162F]VHL; wild type human VHL and VHL mutant [L158P]VHL containing an N-terminal His6 tag (His·VHLWT and His·VHLL158P); human Cul2; human Elongin B; human Elongin B containing an N-terminal His6 tag and a C-terminal HPC4 tag (His·HPC4EloB); mouse wild type Rbx1 and Rbx1 mutant [C94S]Rbx1 containing an N-terminal Myc tag (Myc·Rbx1WT and Myc·Rbx1C94S); S. cerevisiae Rbx1 containing N-terminal His6 and Myc tags (His-Myc·scRbx1); S. cerevisiae Cdc4 containing N-terminal His6 and HSV tags (His-HSV·Cdc4); Cdc4VHL chimeric protein containing N-terminal His6 and FLAG tags; and human Elongin C were subcloned into pBacPAK8. Recombinant baculoviruses were generated with the BacPAK baculovirus expression system (CLONTECH). The baculoviruses encoding mouse Rbx1 containing N-terminal His6 and Myc tags, (His-Myc·Rbx1) (32Kamura T. Koepp D.M. Conrad M.N. Skowyra D. Moreland R.J. Iliopoulos O. Lane W.S. Kaelin W.G. Elledge S.J. Conaway R.C. Harper J.W. Conaway J.W. Science. 1999; 284: 657-661Crossref PubMed Scopus (660) Google Scholar), S. cerevisiae Cdc53 (33Willems A.R. Lanker S. Patton E.E. Craig K.L. Nason T.F. Mathias M. Kobayashi R. Wittenburg C. Tyers M. Cell. 1996; 86: 453-463Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar), and S. cerevisiae Skp1 containing three N-terminal FLAG tags (FLAG-Skp1) (34Skowyra D. Craig K.L. Tyers M. Elledge S.J. Harper J.W. Cell. 1997; 91: 209-219Abstract Full Text Full Text PDF PubMed Scopus (1019) Google Scholar), have been described previously. Sf21 cells were cultured in Sf-900 II serum-free medium with 5% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 μg/ml) at 27 °C. Sf21 cells were coinfected with the recombinant baculoviruses indicated in the figures. Sixty hours after infection, cells were collected and lysed in ice-cold buffer containing 40 mm Hepes-NaOH (pH 7.9), 150 mm NaCl, 1 mm DTT, 0.5% (v/v) Triton X-100, 10% (v/v) glycerol, 5 μg/ml leupeptin, 5 μg/ml antipain, 5 μg/ml pepstatin A, and 5 μg/ml aprotinin. In some experiments, cells were resuspended in ice-cold buffer containing 40 mm Hepes-NaOH (pH 7.9), 150 mm NaCl, 20 mm imidazole (pH 7.9), 5 μg/ml leupeptin, 5 μg/ml antipain, 5 μg/ml pepstatin A, and 5 μg/ml aprotinin and lysed by French press (1 inch piston, 16,000 psi cell pressure; American Instrument Company). Sf21 cells were coinfected with the baculoviruses indicated in the figure legends. Cells were harvested and lysed using a French press as described above. Following centrifugation at 10,000 × g for 20 min at 4 °C, the resulting supernatant was mixed with 1 ml of Ni2+-agarose pre-equilibrated in buffer containing 40 mm Hepes-NaOH (pH 7.9), 150 mm NaCl, and 20 mm imidazole (pH 7.9). After 2 h, the Ni2+-agarose was washed three times with the same buffer and packed into a 0.8-cm diameter column. The column was eluted stepwise with buffer containing 40 mm Hepes-NaOH (pH 7.9), 50 mm NaCl, 300 mm imidazole (pH 7.9), and 10% (v/v) glycerol. Peak fractions containing the recombinant proteins were diluted with 40 mm Tris-HCl (pH 7.9), 10% (v/v) glycerol, 1 mm DTT, and 0.5 mm EDTA and brought to a conductivity equivalent to that of the same buffer containing 40 mm KCl. Following centrifugation at 10,000 ×g for 20 min at 4 °C, the resulting supernatant was applied to a TSK DEAE-NPR HPLC column (4.6 × 35 mm; Toso-Haas) pre-equilibrated in buffer containing 40 mmTris-HCl (pH 7.9), 40 mm KCl, 10% (v/v) glycerol, 1 mm DTT, and 0.5 mm EDTA. The column was eluted at 0.2 ml/min with a 5-ml linear gradient from 40 to 550 mmKCl, and 0.2-ml fractions were collected. Sf21 and 293T cells were harvested and lysed as described above. Cell lysates were incubated for 2 h at 4 °C with protein A-Sepharose and the antibodies indicated in the figure legends. Protein A-Sepharose was washed three times in buffer containing 40 mm Hepes-NaOH (pH 7.9), 150 mm NaCl, 1 mm DTT, 0.5 mm EDTA (pH 7.9), and 0.5% (v/v) Triton X-100. Immunoprecipitated proteins were separated by SDS-polyacrylamide gel electrophoresis, transferred to Hybond P membranes (AmershamBiosciences), and visualized by Western blotting with Supersignal West Pico chemiluminescent reagent (Pierce). To assay immunoprecipitated CBCVHL and SCFCdc4 complexes for their abilities to ubiquitylate the VHL protein, Sf21 cells coinfected with the baculoviruses indicated in the figures were lysed with ice-cold buffer containing 40 mm Hepes-NaOH (pH 7.9), 150 mm NaCl, 1 mm DTT, 0.5% (v/v) Triton X-100, 10% (v/v) glycerol, 5 μg/ml leupeptin, 5 μg/ml antipain, 5 μg/ml pepstatin A, and 5 μg/ml aprotinin. After centrifugation at 10,000 × g for 20 min at 4 °C, the supernatants were immunoprecipitated with 2 μg of anti-VHL (Ig32), anti-FLAG, or anti-HPC4 antibodies and 10 μl of protein A-Sepharose. The beads were mixed with ∼50 ng of Uba1, ∼3 μg of GST·UbK48R, and either ∼100 ng of hUbc5a or ∼200 ng of ScCdc34 in a 20-μl reaction containing 40 mm Hepes-NaOH (pH 7.9), 60 mm potassium acetate, 2 mm DTT, 5 mm MgCl2, 0.5 mm EDTA (pH 7.9), 10% (v/v) glycerol, and 1.5 mm ATP. Reaction mixtures were incubated for 1 h at 26 °C. To assay the abilities of purified recombinant CBC and SCF complexes to ubiquitylate VHL, Cdc4VHL, and Cdc4 proteins, aliquots of TSK DEAE-NPR HPLC column fractions indicated in the figures were mixed with ∼50 ng of Uba1, ∼3 μg of GST·UbK48R, and either ∼100 ng of hUbc5a or ∼200 ng of ScCdc34 in a 10-μl reaction containing 40 mm Hepes-NaOH (pH 7.9), 60 mm potassium acetate, 2 mm DTT, 5 mm MgCl2, 0.5 mm EDTA (pH 7.9), 10% (v/v) glycerol, and 1.5 mm ATP. Reaction mixtures were incubated for 1 h at 26 °C. The observation that VHL is more stable in cells when it is associated with Elongins B and C (22Schoenfeld A.R. Davidowitz E.J. Burk R.D. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 8507-8512Crossref PubMed Scopus (97) Google Scholar) raised the possibility that the VHL protein might be protected from ubiquitylation and subsequent degradation by assembly into the CBCVHL complex. To address this possibility directly, Sf21 insect cells were coinfected with various combinations of baculoviruses encoding Cul2, Rbx1, Elongins B and C, and either wild type VHL, VHL mutant [K159R,K171R,K196R]VHL, which has no lysines and therefore cannot be ubiquitylated, or VHL mutants [L158P]VHL and [C162F]VHL, which exhibit substantially reduced affinities for Elongins B and C. We note that although Elongin C is capable of interacting with VHL in the absence of Elongin B, Elongins B and C were always coexpressed together in these experiments for the following reasons. (i) The binding of Elongin C to VHL is stabilized by Elongin B both in vitro and in cells (16Duan D.R. Pause A. Burgess W.H. Aso T. Chen D.Y.T. Garrett K.P. Conaway R.C. Conaway J.W. Linehan W.M. Klausner R.D. Science. 1995; 269: 1402-1406Crossref PubMed Scopus (506) Google Scholar, 35Pause A. Peterson B. Schaffar G. Stearman R. Klausner R.D. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 9533-9538Crossref PubMed Scopus (81) Google Scholar). (ii) Elongin C is stabilized and expressed to considerably higher levels in insect cells that also express Elongin B (data not shown). (iii) The detectable Elongin C is always found in association with Elongin B during biochemical purification of Elongin C-containing complexes (Ref. 36Kamura T. Sato S. Haque D. Liu L. Kaelin W.G. Conaway R.C. Conaway J.W. Genes Dev. 1998; 12: 3872-3881Crossref PubMed Scopus (498) Google Scholar and data not shown). VHL-containing complexes were immunoprecipitated with an anti-VHL monoclonal antibody and tested for their susceptibility to VHL ubiquitylation. In these experiments, immunopurified complexes (Fig.1A, lanes 1–9) were incubated with an E1 ubiquitin-activating enzyme, the E2 ubiquitin-conjugating enzyme Ubc5a, ubiquitin (GST·UbK48R), and ATP. Reaction products were analzyed by Western blotting with anti-VHL antibody. As shown in Fig.1B, maximal formation of the more slowly migrating VHL-GST·UbK48R conjugates was observed in reactions performed with VHL complexes immunoprecipitated from insect cells expressing wild type VHL, Cul2, and Rbx1 (lane 2). Formation of these more slowly migrating species was strongly inhibited by the presence of Elongins B and C (lanes 3 and 7) and was not observed in VHL immunoprecipitates from insect cells expressing the [K159R,K171R,K196R]VHL mutant (lanes 4 and 5). Further supporting the notion that binding of Elongins B and C to VHL blocks its ubiquitylation, VHL mutants [L158P]VHL and [C162F]VHL are more efficiently ubiquitylated than wild type VHL, even when present in VHL immunoprecipitates from cells expressing high levels of Elongins B and C (lanes 8 and 9). To confirm and extend these findings, wild type VHL, Cul2, Rbx1, Elongin C, and an epitope-tagged Elongin B (HPC4·EloB) were coexpressed in insect cells and coimmunopurified with anti-HPC4 monoclonal antibodies. This procedure ensured that all of the immunoprecipitated VHL protein was associated with Elongins B and C. As shown in Fig. 1A, lanes 10 and 11, anti-HPC4 immunoprecipitates contained all five subunits of the CBCVHL complex. Notably, the VHL protein contained in these Elongin B-containing complexes was resistant to ubiquitylation (Fig. 1B, lanes 10and 11). The results of the experiments described above argue that VHL ubiquitylation can be negatively regulated by its binding to Elongins B and C and/or by its assembly into complete CBCVHL complexes containing Cul2, Elongins B and C, and Rbx1. However, they provide no information about the mechanism of VHL ubiquitylation outside the context of CBCVHL. In the course of investigating interactions among subunits of the CBCVHL complex, we have observed that Rbx1 binds to VHL in the absence of exogenously expressed Cul2 and Elongins B and C (32Kamura T. Koepp D.M. Conrad M.N. Skowyra D. Moreland R.J. Iliopoulos O. Lane W.S. Kaelin W.G. Elledge S.J. Conaway R.C. Harper J.W. Conaway J.W. Science. 1999; 284: 657-661Crossref PubMed Scopus (660) Google Scholar), raising the possibility that Rbx1 might be capable of directly activating VHL ubiquitylation. To address this possibility, His6-tagged wild type VHL or His6-tagged [L158P]VHL were expressed in Sf21 insect cells alone, with Rbx1, or in combination with Rbx1, Cul2, and Elongins B and C. VHL or VHL-containing complexes were purified from cell lysates by consecutive Ni2+-agarose chromatography and TSK DEAE-NPR HPLC. As shown in the Coomassie Blue-stained SDS-polyacrylamide gel in Fig.2A, wild type VHL could be purified as an approximately stoichiometric component of the complete CBCVHL complex. In addition, both wild type VHL and the [L158P]VHL mutant could be purified with approximately stoichiometric amounts of Rbx1 in the absence of exogenously expressed Cul2 and Elongins B and C. Purified VHL and VHL-containing complexes were incubated with E1 ubiquitin-activating enzyme, the E2 ubiquitin-conjugating enzyme Ubc5a, GST·UbK48R, and ATP. Consistent with the results in Fig.1, we observed no detectable ubiquitylation of VHL in the context of the purified CBCVHL complex. Purified VHL and [L158P]VHL formed VHL-UbK48R conjugates with electrophoretic mobilities corresponding to those expected for addition of a single GST·UbK48R. In contrast, high molecular mass VHL-GST·UbK48R conjugates were formed when VHL and [L158P]VHL were present as components of VHLRbx1complexes (Fig. 2, B and C). To investigate further the requirement for Rbx1 in the formation of high molecular mass VHL-GST·UbK48R conjugates, we compared VHL ubiquitylation in the presence of wild type Rbx1 and the Rbx1 mutant [C94S], which does not support activation of either Cdc34-dependent ubiquitylation of Cln2 by SCFGrr1 complexes or Ubc12-dependent Rub1 modification of Cullin proteins (31Kamura T. Conrad M.N. Yan Q. Conaway R.C. Conaway J.W. Genes Dev. 1999; 13: 2928-2933Crossref PubMed Scopus (232) Google Scholar). In these experiments, His6-tagged VHL was coexpressed in insect cells with either Rbx1 or [C94S]Rbx1. The resulting complexes were purified from cell lysates by consecutive Ni2+-agarose chromatography and TSK DEAE-NPR HPLC. As shown in Fig.3A, approximately stoichiometric amounts of both wild type and mutant Rbx1 copurified with the VHL protein. In addition, high molecular mass VHL-GST·UbK48R conjugates were formed only in the presence of wild type Rbx1 (Fig. 3, B and C), indicating that VHL ubiquitylation depends on the presence of functional Rbx1. The S. cerevisiae F-box protein Cdc4 is rapidly ubiquitylated and degraded by the proteasome in cells (18Galan J.-M. Peter M. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 9124-9129Crossref PubMed Scopus (225) Google Scholar, 19Zhou P. Howley P.M. Mol. Cell. 1998; 2: 571-580Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar). Based on the observations that (i) Cdc4 turnover depends upon its ability to interact with the SCF components Skp1 and Cdc53, and (ii) Cdc4 is stabilized when cells containing a temperature-sensitive Skp1 mutant are grown at the non-permissive temperature, it has been proposed that Cdc4 can be ubiquitylated in the context of an SCFCdc4 complex (18Galan J.-M. Peter M. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 9124-9129Crossref PubMed Scopus (225) Google Scholar, 19Zhou P. Howley P.M. Mol. Cell. 1998; 2: 571-580Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar). However, direct evidence in support of this model has not been reported. To test this possibility, we asked whether a recombinant SCFCdc4complex, expressed in and purified from Sf21 insect cells, is capable of promoting Cdc4 ubiquitylation. N-terminal His6- and HSV-tagged Cdc4 (His-HSV·Cdc4), S. cerevisiae Cdc53, N-terminal FLAG-tagged S. cerevisiae Skp1 (FLAG-Skp1), and N-terminal His6- and Myc-tagged S. cerevisiaeRbx1 (His-Myc·ScRbx1) were coexpressed in Sf21 insect cells and purified from cell lysates by consecutive Ni2+-agarose chromatography and TSK DEAE-NPR HPLC. The purified SCFCdc4complexes are shown in Fig.4A, left panel. As shown in Fig. 4A, right panel, high molecular mass Cdc4-GST·UbK48R conjugates appeared in a time-dependent manner following incubation of the purified SCFCdc4 complexes with E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme Cdc34, GST·UbK48R, and ATP. Although these results strongly suggested that Cdc4 can be ubiquitylated in the context of the SCFCdc4 complex, it was possible that the ubiquitylated Cdc4 in these reactions was not actually a component of SCF complexes but rather represented contaminating free Cdc4 in the purified SCFCdc4 fraction. To prepare SCFCdc4 complexes free of contaminating Cdc4, SCF subunits were coexpressed in insect cells and immunoprecipitated from cell lysates with antibodies recognizing the FLAG epitope on Skp1 (Fig. 4B, left panel). Immunoprecipitated complexes were then incubated with E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme Cdc34, GST·UbK48R, and ATP. As shown in Fig. 4B (right panel), similar to the results obtained with chromatographically purified SCFCdc4complexes, high molecular mass Cdc4-GST·UbK48R conjugates were also formed in the presence of immunoprecipitated complexes. Thus, unlike the VHL protein in the CBCVHL complex, the Cdc4 protein can be ubiquitylated in the context of the SCFCdc4complex. To account for the observation that Cdc4, a target recruitment subunit of the SCF complex, can be ubiquitylated in the context of SCFCdc4 (whereas VHL, a CBC target recruitment subunit, is protected from ubiquitylation in the context of CBCVHL), we considered the possibility that CBC complexes might be inherently incapable of supporting ubiquitylation of associated target recruitment subunits. To address this hypothesis, we constructed an N-terminal His6-tagged Cdc4VHLchimera that contained the entire VHL open reading frame, including the BC-box and the Cdc4 WD-40 repeat domain but lacked the Cdc4 F-box (Fig.5A). The Cdc4VHLchimera was coexpressed in Sf21 insect cells with Cul2, Rbx1, and Elongins B and C; the resulting CBC-Cdc4VHL complex was purified from cell lysates by consecutive Ni2+-agarose chromatography and TSK DEAE-NPR HPLC. The purified CBC-Cdc4VHL complex is shown in Fig. 5B. As shown in Fig. 5C, high molecular mass Cdc4VHL-UbK48R conjugates were formed in a time-dependent manner following incubation of the purified CBC-Cdc4VHL complex with E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme Ubc5a, GST·UbK48R, and ATP, indicating that the Cdc4VHL chimera can be ubiquitylated in the context of the CBC-Cdc4VHL complex. Thus, the resistance of VHL to ubiquitylation in the context of the CBCVHL complex does not reflect an inherent inability of CBC complexes to ubiquitylate their target recruitment subunits, and therefore resistance to ubiquitylation must be a property of the VHL protein itself. In this report we have investigated the molecular basis of the different modes of regulation of the VHL tumor suppressor protein as the target recruitment subunit of the CBCVHL ubiquitin ligase and of F-box proteins as target recruitment subunits of the structurally related SCF ubiquitin ligases. Our findings provide a plausible model to explain the different stabilities of the VHL and of F-box proteins in cells. Unlike the F-box proteins Cdc4, Grr1, and Met30, which can be ubiquitylated in the context of the SCF and degraded by the proteasome, the VHL protein is resistant to ubiquitylation in the context of the CBCVHLcomplex, thus accounting at least in part for its long half-life in cells and consistent with its continuous requirement in negative regulation of the levels of hypoxia-inducible transcription factors throughout all phases of the cell cycle. Our observation that the Cdc4VHL chimera can be ubiquitylated in the context of the CBC-Cdc4VHL complex suggests that the resistance of VHL to ubiquitylation in the CBCVHL complex is not an intrinsic property of the CBC complex conferred by one or more of its Cul2, Rbx1, and Elongin B and C subunits but instead is a property of the VHL protein regulated by the geometry of the CBCVHL complex. The human VHL protein contains three lysine residues that are found in its C-terminal α-domain (37Stebbins C.E. Kaelin W.G. Pavletich N.P. Science. 1999; 284: 455-461Crossref PubMed Scopus (673) Google Scholar) at positions 159, 171, and 196 and that are potential ubiquitylation sites. The lysine at position 159, which is located within the Elongin BC binding site and is hydrogen-bonded to Asn-108 of Elongin C, would be predicted to be protected from ubiquitylation by interaction of VHL with Elongins B and C. The lysines at positions 171 and 196 lie on exposed surfaces of VHL within the VHL-Elongin BC complex. Whether Cul2 and Rbx1 physically block access of the E2 to Lys-171 and -196 or whether some other aspect(s) of the geometry of the complex prevents their ubiquitylation awaits structural studies of the intact CBCVHL complex. Interestingly, in recent experiments we have observed that, although the E2 ubiquitin-conjugating enzymes Ubc5 and Cdc34 can both be activated to synthesize polyubiquitin chains conjugated to Cul2 in the context of the CBC complex, the two enzymes transfer ubiquityl moieties to lysines at different sites on Cul2. 2T. Kamura, R. C. Conaway, J. W. Conaway, and Qin Yan, unpublished results.Thus, the overall geometry of lysines on the surface of target proteins is likely to contribute to regulation of their ubiquitylation by CBC and SCF ubiquitin ligases. Experiments are underway to decipher the rules governing the choice of surface lysines by different E2 enzymes and should shed light on this mode of regulation. We thank A. Weissman (National Institutes of Health) for cDNA encoding hUbc5a, J. W. Harper and S. Elledge (Baylor) for baculoviruses encoding Cdc53 and Skp1, and F. Barnett for help with preparation of the figures." @default.
• W2093622484 created "2016-06-24" @default.
• W2093622484 creator A5052944925 @default.
• W2093622484 creator A5054486813 @default.
• W2093622484 creator A5060208809 @default.
• W2093622484 creator A5066462882 @default.
• W2093622484 date "2002-08-01" @default.
• W2093622484 modified "2023-10-17" @default.
• W2093622484 title "A Molecular Basis for Stabilization of the von Hippel-Lindau (VHL) Tumor Suppressor Protein by Components of the VHL Ubiquitin Ligase" @default.
• W2093622484 cites W1749022239 @default.
• W2093622484 cites W1832030339 @default.
• W2093622484 cites W1964037605 @default.
• W2093622484 cites W1972032694 @default.
• W2093622484 cites W1976955696 @default.
• W2093622484 cites W1978173977 @default.
• W2093622484 cites W1982290796 @default.
• W2093622484 cites W1987399378 @default.
• W2093622484 cites W1988935612 @default.
• W2093622484 cites W1991843895 @default.
• W2093622484 cites W1994282776 @default.
• W2093622484 cites W2005812143 @default.
• W2093622484 cites W2015817451 @default.
• W2093622484 cites W2015997780 @default.
• W2093622484 cites W2022376508 @default.
• W2093622484 cites W2031514188 @default.
• W2093622484 cites W2033228162 @default.
• W2093622484 cites W2039310836 @default.
• W2093622484 cites W2057075902 @default.
• W2093622484 cites W2075054245 @default.
• W2093622484 cites W2075124527 @default.
• W2093622484 cites W2076665343 @default.
• W2093622484 cites W2079760361 @default.
• W2093622484 cites W2080374319 @default.
• W2093622484 cites W2087841059 @default.
• W2093622484 cites W2108366666 @default.
• W2093622484 cites W2121781216 @default.
• W2093622484 cites W2134780468 @default.
• W2093622484 cites W2140496726 @default.
• W2093622484 cites W2147718842 @default.
• W2093622484 cites W2149268957 @default.
• W2093622484 cites W2150621953 @default.
• W2093622484 cites W2166987747 @default.
• W2093622484 cites W2170634115 @default.
• W2093622484 cites W2172170481 @default.
• W2093622484 doi "https://doi.org/10.1074/jbc.m203344200" @default.
• W2093622484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12048197" @default.
• W2093622484 hasPublicationYear "2002" @default.
• W2093622484 type Work @default.
• W2093622484 sameAs 2093622484 @default.
• W2093622484 citedByCount "55" @default.
• W2093622484 countsByYear W20936224842012 @default.
• W2093622484 countsByYear W20936224842014 @default.
• W2093622484 countsByYear W20936224842015 @default.
• W2093622484 countsByYear W20936224842016 @default.
• W2093622484 countsByYear W20936224842017 @default.
• W2093622484 countsByYear W20936224842018 @default.
• W2093622484 countsByYear W20936224842020 @default.
• W2093622484 countsByYear W20936224842022 @default.
• W2093622484 crossrefType "journal-article" @default.
• W2093622484 hasAuthorship W2093622484A5052944925 @default.
• W2093622484 hasAuthorship W2093622484A5054486813 @default.
• W2093622484 hasAuthorship W2093622484A5060208809 @default.
• W2093622484 hasAuthorship W2093622484A5066462882 @default.
• W2093622484 hasBestOaLocation W20936224841 @default.
• W2093622484 hasConcept C104317684 @default.
• W2093622484 hasConcept C134459356 @default.
• W2093622484 hasConcept C153911025 @default.
• W2093622484 hasConcept C175114707 @default.
• W2093622484 hasConcept C179185449 @default.
• W2093622484 hasConcept C185592680 @default.
• W2093622484 hasConcept C25602115 @default.
• W2093622484 hasConcept C2908868211 @default.
• W2093622484 hasConcept C502942594 @default.
• W2093622484 hasConcept C55493867 @default.
• W2093622484 hasConcept C86803240 @default.
• W2093622484 hasConcept C95444343 @default.
• W2093622484 hasConceptScore W2093622484C104317684 @default.
• W2093622484 hasConceptScore W2093622484C134459356 @default.
• W2093622484 hasConceptScore W2093622484C153911025 @default.
• W2093622484 hasConceptScore W2093622484C175114707 @default.
• W2093622484 hasConceptScore W2093622484C179185449 @default.
• W2093622484 hasConceptScore W2093622484C185592680 @default.
• W2093622484 hasConceptScore W2093622484C25602115 @default.
• W2093622484 hasConceptScore W2093622484C2908868211 @default.
• W2093622484 hasConceptScore W2093622484C502942594 @default.
• W2093622484 hasConceptScore W2093622484C55493867 @default.
• W2093622484 hasConceptScore W2093622484C86803240 @default.
• W2093622484 hasConceptScore W2093622484C95444343 @default.
• W2093622484 hasIssue "33" @default.
• W2093622484 hasLocation W20936224841 @default.
• W2093622484 hasLocation W20936224842 @default.
• W2093622484 hasOpenAccess W2093622484 @default.
• W2093622484 hasPrimaryLocation W20936224841 @default.
• W2093622484 hasRelatedWork W2007249806 @default.
• W2093622484 hasRelatedWork W2025483613 @default.
• W2093622484 hasRelatedWork W2040509817 @default.
• W2093622484 hasRelatedWork W2056589762 @default.
• W2093622484 hasRelatedWork W2097763804 @default.

• next